Medical Affairs and Scientific Communications Forum
Medical Communication, MSL, and Medical Writing.
Session 8 Track 1: Gold! Gold! Gold from Medical Information!
Ivy Lee Chang, PharmD
Associate Director, Medical Communications
Genentech, Inc., A Member of the Roche Group, United States
Medical information/communications (MI) departments within the pharmaceutical and biotech industry have existed for decades. These departments have also been documenting unsolicited drug information requests in electronic databases and utilizing the metrics to enhance data capture, business processes and workflows. While these efforts have served to improve the operations of the MI department, ongoing challenges in demonstrating the value and impact of the MI function remain. The database documenting the MI requests is a gold mine with untapped potential. Sharing the metrics is easy, but what do the metrics mean without context? What are some key performance indicators that can showcase the value of MI? What are insights, how are these identified, and who should be the audience of these? During this session the faculty will share their views and experiences on demonstrating the value of medical information.
Learning Objective : At the conclusion of this session, participants should be able to:
Define insights and key performance indicators (KPIs)
Identify insights from medical information request metrics and customer feedback
Identify key internal stakeholders with whom to share various metrics, insights, and KPI
Integrate value of Medical Information through customer insights and KPIs
Vertex Pharmaceuticals, United States
Joyce P. Fairclough, PharmD
Senior Manager, Medical Information Services
Sanofi, United States
Kim Lee, PharmD
Director, Multiple Myeloma Team Lead, Global Medical Information